One of this century’s biggest game-changers will likely be a novel drug class that’s showing unprecedented success, or the promise of it, in treating some of the world’s most prevalent conditions.
Companies are increasingly investing in ESG (Environmental, Social, and Governance) initiatives to meet regulations, trends, and consumer expectations. Understanding these expectations is crucial for aligning ESG strategies with consumer values and achieving brand success.
Asia Pacific open to digital and reform transformation, but concerned about pace of change: can business and government leaders guide the change revolution?